Top 100 scientists can be ranked globally or specific to the following regions including Africa, Asia, Europe, North America, Latin America, Oceania, Arab League, ASEAN, EECA, and BRICS based on total H-index scores without any breakdown by subject areas. Top 100 rankings in the world, in a continent, or a region include standardized subjects areas of Agriculture & Forestry, Arts, Design and Architecture, Business & Management, Economics & Econometrics, Education, Engineering & Technology, History, Philosophy, Theology, Law/Law and Legal Studies, Medical and Health Sciences, Natural Sciences, Social Sciences, Art and Humanities Rankings and Social Sciences and Humanities Rankings BETA VERSION. Subject field ranking in world, region, country and university is beta version since subject field "others" (873,864 scientists profile whose branch cannot be determined, not yet edited or determined) is excluded, so the ranking will change as the others fields are edited. Please note that. Subjects indicated as “ * others ” will not be included in the ranking by regions and subjects.
pharmacoepidemiology
side effects
drug policy
academic detailing
prescription drugs
Metrics
H-Index
i10 Index
Citation
151
541
123,601
* Rankings
Ranking Based On Selection :2
Pharmaceutical policy
health systems research
quality improvement
Metrics
H-Index
i10 Index
Citation
90
278
30,864
* Rankings
Ranking Based On Selection :3
disease surveillance
infectious disease outbreaks
scan statistics
pharmacoepidemiology
vaccines
Metrics
H-Index
i10 Index
Citation
83
207
32,143
* Rankings
Ranking Based On Selection :4
medicinal chemistry
Metrics
H-Index
i10 Index
Citation
64
209
14,220
* Rankings
Ranking Based On Selection :5
real-world evidence
causal inference
pharmacoepidemiology
drug utilization
Metrics
H-Index
i10 Index
Citation
58
135
11,992
* Rankings
Ranking Based On Selection :6
medicinal chemistry
antitumor and antiviral agents
Metrics
H-Index
i10 Index
Citation
54
198
9,948
* Rankings
Ranking Based On Selection :7
Real-world evidence
medical product safety and effectiveness
pharmacoepidemiology
data science
Metrics
H-Index
i10 Index
Citation
51
189
10,690
* Rankings
Ranking Based On Selection :8
Pharmacoepidemiology
Privacy-protecting methods
Distributed data networks
Real-world evidence
Metrics
H-Index
i10 Index
Citation
48
141
8,630
* Rankings
Ranking Based On Selection :9
Pharmacoepidemiology
Metrics
H-Index
i10 Index
Citation
47
125
8,822
* Rankings
Ranking Based On Selection :10
pharmacology
burn injury
opiates
Metrics
H-Index
i10 Index
Citation
43
106
5,922
* Rankings
Ranking Based On Selection :11
Computational systems biology
real time
hybrid and probabilistic systems.
Metrics
H-Index
i10 Index
Citation
41
97
6,035
* Rankings
Ranking Based On Selection :12
drug delivery
tumor immunology
tumor biology
Metrics
H-Index
i10 Index
Citation
34
44
7,382
* Rankings
Ranking Based On Selection :13
Cardiovascular pharmacotherapy
pharmacology and pharmacoepidemiology
Metrics
H-Index
i10 Index
Citation
33
61
3,829
* Rankings
Ranking Based On Selection :14
Pharmaceutical Policy
Public Health Law
Metrics
H-Index
i10 Index
Citation
29
69
3,961
* Rankings
Ranking Based On Selection :15
Clinical Trials
Pharmacy Informatics
Medication Safety
Metrics
H-Index
i10 Index
Citation
29
43
10,541
* Rankings
Ranking Based On Selection :16
Pharmacoepidemiology
outcomes research
pharmacogenomics
pharmacogenetics
Metrics
H-Index
i10 Index
Citation
26
33
2,916
* Rankings
Ranking Based On Selection :17
Molecular imaging
Metrics
H-Index
i10 Index
Citation
24
49
2,008
* Rankings
Ranking Based On Selection :18
Pharmacogenomics and Placebo Response
Metrics
H-Index
i10 Index
Citation
23
35
2,392
* Rankings
Ranking Based On Selection :19
pharmacoepidemiology
methods
Metrics
H-Index
i10 Index
Citation
23
28
2,032
* Rankings
Ranking Based On Selection :20
Medicinal Chemistry
Molecular Imaging
Drug Discovery and Evaluation
Metrics
H-Index
i10 Index
Citation
23
33
2,760
* Rankings
Ranking Based On Selection :21
Drug Discovery
Virology
Systems Biology
Metrics
H-Index
i10 Index
Citation
22
29
6,810
* Rankings
Ranking Based On Selection :22
Respiratory Disease
Pulmonary Hypertension
Pulmonary Fibrosis
BMP/TGFβ
GPCR
Metrics
H-Index
i10 Index
Citation
21
33
2,084
* Rankings
Ranking Based On Selection :23
Nanopharmaceuticals
bone tissue engineering
Targeted drug delivery
Nonviral gene delivery systems
Metrics
H-Index
i10 Index
Citation
21
24
1,739
* Rankings
Ranking Based On Selection :24
Computational Biology
Metrics
H-Index
i10 Index
Citation
21
24
1,572
* Rankings
Ranking Based On Selection :25
pharmacoepidemiology
health services research
Metrics
H-Index
i10 Index
Citation
21
39
2,045
* Rankings
Ranking Based On Selection :26
Pharmacoepidemiology
Clinical epidemiology
registry studies
Metrics
H-Index
i10 Index
Citation
20
24
1,317
* Rankings
Ranking Based On Selection :27
Computational Medicine
Pharmacometrics
Process Engineering
Numerical Techniques
Machine Learning
Metrics
H-Index
i10 Index
Citation
20
26
1,189
* Rankings
Ranking Based On Selection :28
Infectious Diseases
Antimicrobial Chemotherapy
Pharmacy
Metrics
H-Index
i10 Index
Citation
18
25
1,336
* Rankings
Ranking Based On Selection :29
Pharmaceutical Medicine
Public Health
Metrics
H-Index
i10 Index
Citation
18
20
15,264
* Rankings
Ranking Based On Selection :30
Drug Delivery
Biomaterials
Diagnostics
Metrics
H-Index
i10 Index
Citation
17
24
1,589
* Rankings
Ranking Based On Selection :31
Medicinal Chemistry
Drug Delivery
Pharmacology
Biomedical Engineering
Biophysics
Metrics
H-Index
i10 Index
Citation
16
19
1,574
* Rankings
Ranking Based On Selection :32
Drug development
Metabolic disease
Metrics
H-Index
i10 Index
Citation
14
17
1,054
* Rankings
Ranking Based On Selection :33
Drug Delivery
Metrics
H-Index
i10 Index
Citation
14
14
1,645
* Rankings
Ranking Based On Selection :34
fragment-based drug design
Molecular modeling
Drug discovery
Metrics
H-Index
i10 Index
Citation
14
20
591
* Rankings
Ranking Based On Selection :35
Drug Discovery & Medicinal Chemistry
Total Synthesis
Process Development
Organometallics
Nano Particle
Metrics
H-Index
i10 Index
Citation
14
17
828
* Rankings
Ranking Based On Selection :36
Pharmaceuticals
Medicinal Chemistry
Metrics
H-Index
i10 Index
Citation
14
14
810
* Rankings
Ranking Based On Selection :37
Drug Development - Virology
Metrics
H-Index
i10 Index
Citation
13
14
926
* Rankings
Ranking Based On Selection :38
pharmacoepidemiology
causal inference
infectious disease
Metrics
H-Index
i10 Index
Citation
13
14
763
* Rankings
Ranking Based On Selection :39
Health economics
pharmacoepidemiology
outcomes research
Metrics
H-Index
i10 Index
Citation
13
15
726
* Rankings
Ranking Based On Selection :40
Pharmacology
Metrics
H-Index
i10 Index
Citation
12
12
430
* Rankings
Ranking Based On Selection :41
Drug discovery
drug development
toxicology
mRNA therapeutics
Metrics
H-Index
i10 Index
Citation
12
13
449
* Rankings
Ranking Based On Selection :42
Radiopharmaceuticals
Metrics
H-Index
i10 Index
Citation
11
14
603
* Rankings
Ranking Based On Selection :43
Pharmacy
Critical Care
Transitions of Care
Metrics
H-Index
i10 Index
Citation
10
10
970
* Rankings
Ranking Based On Selection :44
Medicinal Chemistry
Metrics
H-Index
i10 Index
Citation
10
10
532
* Rankings
Ranking Based On Selection :45
Pharmacovigilance
Harm Reduction
Cryptomarkets
Behavioral Economics
Drug Policy
Metrics
H-Index
i10 Index
Citation
9
9
1,122
* Rankings
Ranking Based On Selection :46
Pharmaceutical policy
innovation
Metrics
H-Index
i10 Index
Citation
9
9
423
* Rankings
Ranking Based On Selection :47
Pharmaceutical Sciences
Gene and drug delivery
Nanomedicine
Biomaterials
Metrics
H-Index
i10 Index
Citation
9
9
359
* Rankings
Ranking Based On Selection :48
Pharmacoepidemiology
Metrics
H-Index
i10 Index
Citation
9
8
235
* Rankings
Ranking Based On Selection :49
Drug Discovery
Antibiotic Discovery and Development
Metrics
H-Index
i10 Index
Citation
8
8
279
* Rankings
Ranking Based On Selection :50
Pharmacology
Corneal angiogenesis
Neurotrophic Keratopathy
BMP signaling
Pharmacovigilance
Metrics
H-Index
i10 Index
Citation
8
7
248
* Rankings
Ranking Based On Selection :51
Pharmacology
Neuropharmacology
Neuroscience
Alzheimer's Disease
Metrics
H-Index
i10 Index
Citation
8
8
242
* Rankings
Ranking Based On Selection :52
Drug Target Identification and Drug Resistance in Malaria
Metrics
H-Index
i10 Index
Citation
7
7
161
* Rankings
Ranking Based On Selection :53
Pharmacology. Neurodegeneration. Alzheimer's disease.
Metrics
H-Index
i10 Index
Citation
7
6
304
* Rankings
Ranking Based On Selection :54
Drug Delivery Systems
Nanoscience and Nanotechnology
Biomaterials
Metrics
H-Index
i10 Index
Citation
7
6
215
* Rankings
Ranking Based On Selection :55
Pharmacology
Immunology
Metrics
H-Index
i10 Index
Citation
7
6
179
* Rankings
Ranking Based On Selection :56
Pharmacology
Trace Amines
Chemosensing
Epithelial Biology
Metrics
H-Index
i10 Index
Citation
7
6
160
* Rankings
Ranking Based On Selection :57
Drug Discovery and development
Metrics
H-Index
i10 Index
Citation
7
6
906
* Rankings
Ranking Based On Selection :58
pharmacoepidemiology
comparative effectiveness research
real-world evidence
oncology
clinical pharmacy
Metrics
H-Index
i10 Index
Citation
6
4
134
* Rankings
Ranking Based On Selection :59
Pharmacogenomics
Precision Oncology
Clinical Bioinformatics
Decision Intelligence
Metrics
H-Index
i10 Index
Citation
6
3
80
* Rankings
Ranking Based On Selection :60
Pharmacoepidemiology
Metrics
H-Index
i10 Index
Citation
5
3
151
* Rankings
Ranking Based On Selection :61
drug discovery
biochemistry
biophysics
chemical biology
Metrics
H-Index
i10 Index
Citation
5
4
131
* Rankings
Ranking Based On Selection :62
Pharmacy
nanotechnology
nanocapsules
autoimmune diseases
immunology
Metrics
H-Index
i10 Index
Citation
3
2
76
* Rankings
Ranking Based On Selection :63
pharmaceutical innovation
health economics
Metrics
H-Index
i10 Index
Citation
3
2
51
* Rankings
Ranking Based On Selection :64
Neuroscience
Metrics
H-Index
i10 Index
Citation
3
2
37
* Rankings
Ranking Based On Selection :65
Internal medicine
infectious diseases
venous thromboembolism
anticoagulation
diabetes mellitus
Metrics
H-Index
i10 Index
Citation
3
1
44
* Rankings
Ranking Based On Selection :66
Researcher
Metrics
H-Index
i10 Index
Citation
2
1
32
Jerry Avorn
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
151
541
123,601
pharmacoepidemiology
side effects
drug policy
academic detailing
prescription drugs
Dennis Ross Degnan
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
90
278
30,864
Pharmaceutical policy
health systems research
quality improvement
Martin Kulldorff
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
83
207
32,143
disease surveillance
infectious disease outbreaks
scan statistics
pharmacoepidemiology
vaccines
Michael Chorev
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
64
209
14,220
Jessica Myers Franklin|Jessica A. Myers
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
58
135
11,992
real-world evidence
causal inference
pharmacoepidemiology
drug utilization
Andre Rosowsky
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
54
198
9,948
medicinal chemistry
antitumor and antiviral agents
Joshua J Gagne
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
51
189
10,690
Real-world evidence
medical product safety and effectiveness
pharmacoepidemiology
data science
Sengwee Darren Toh
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
48
141
8,630
Pharmacoepidemiology
Privacy-protecting methods
Distributed data networks
Real-world evidence
Rishi J Desai
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
47
125
8,822
Jeevendra A Martyn
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
43
106
5,922
pharmacology
burn injury
opiates
PS Thiagarajan
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
41
97
6,035
Computational systems biology
real time
hybrid and probabilistic systems.
Zohreh Amoozgar
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
34
44
7,382
drug delivery
tumor immunology
tumor biology
Leo F Buckley
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
33
61
3,829
Cardiovascular pharmacotherapy
pharmacology and pharmacoepidemiology
Ameet Sarpatwari
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
29
69
3,961
Pharmaceutical Policy
Public Health Law
Andrew C Seger
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
29
43
10,541
Clinical Trials
Pharmacy Informatics
Medication Safety
Peter M Wahl
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
26
33
2,916
Pharmacoepidemiology
outcomes research
pharmacogenomics
pharmacogenetics
Kai Bao
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
24
49
2,008
Hall Kathryn
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
23
35
2,392
Pharmacogenomics and Placebo Response
Shirley V Wang
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
23
28
2,032
pharmacoepidemiology
methods
Ashfaq Mahmood
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
23
33
2,760
Medicinal Chemistry
Molecular Imaging
Drug Discovery and Evaluation
Xu Tan
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
22
29
6,810
Drug Discovery
Virology
Systems Biology
Peiran Yang
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
21
33
2,084
Respiratory Disease
Pulmonary Hypertension
Pulmonary Fibrosis
BMP/TGFβ
GPCR
Marzieh Mohammadi
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
21
24
1,739
Nanopharmaceuticals
bone tissue engineering
Targeted drug delivery
Nonviral gene delivery systems
Fabian Fröhlich
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
21
24
1,572
Katsiaryna Bykov
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
21
39
2,045
pharmacoepidemiology
health services research
Hiraku Kumamaru
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
20
24
1,317
Pharmacoepidemiology
Clinical epidemiology
registry studies
Anwesha Chaudhury
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
20
26
1,189
Computational Medicine
Pharmacometrics
Process Engineering
Numerical Techniques
Machine Learning
David W Kubiak
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
18
25
1,336
Infectious Diseases
Antimicrobial Chemotherapy
Pharmacy
Eduardo Sabate
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
18
20
15,264
Pharmaceutical Medicine
Public Health
Simon Matoori
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
17
24
1,589
Drug Delivery
Biomaterials
Diagnostics
Baowen Qi
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
16
19
1,574
Medicinal Chemistry
Drug Delivery
Pharmacology
Biomedical Engineering
Biophysics
Rucha Patel
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
14
17
1,054
Drug development
Metabolic disease
Douglas R Vogus
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
14
14
1,645
Yanmin Zhang
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
14
20
591
fragment-based drug design
Molecular modeling
Drug discovery
Sha Bai
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
14
17
828
Drug Discovery & Medicinal Chemistry
Total Synthesis
Process Development
Organometallics
Nano Particle
Partha P Chakrabarti
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
14
14
810
Pharmaceuticals
Medicinal Chemistry
Alex Kintu
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
13
14
926
Drug Development - Virology
Carly A Rodriguez
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
13
14
763
pharmacoepidemiology
causal inference
infectious disease
Nicole W Tsao
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
13
15
726
Health economics
pharmacoepidemiology
outcomes research
Sarah Withey
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
12
12
430
Lorna Cryan
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
12
13
449
Drug discovery
drug development
toxicology
mRNA therapeutics
Bo Yeun Yang
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
11
14
603
John Marshall
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
10
10
970
Pharmacy
Critical Care
Transitions of Care
Yiqiang Wang
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
10
10
532
Michael Gilbert
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
9
9
1,122
Pharmacovigilance
Harm Reduction
Cryptomarkets
Behavioral Economics
Drug Policy
Changwon C. Lee
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
9
9
423
Pharmaceutical policy
innovation
Weimin Tang
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
9
9
359
Pharmaceutical Sciences
Gene and drug delivery
Nanomedicine
Biomaterials
ChunTing Yang
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
9
8
235
Antonio Ramkissoon
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
8
8
279
Drug Discovery
Antibiotic Discovery and Development
Sheyda Najafi
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
8
7
248
Pharmacology
Corneal angiogenesis
Neurotrophic Keratopathy
BMP signaling
Pharmacovigilance
Kelly A. Krogh
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
8
8
242
Pharmacology
Neuropharmacology
Neuroscience
Alzheimer's Disease
Akansha Pant
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
7
7
161
Drug Target Identification and Drug Resistance in Malaria
Camila A Zanella
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
7
6
304
Pharmacology. Neurodegeneration. Alzheimer's disease.
Gil Aizik
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
7
6
215
Drug Delivery Systems
Nanoscience and Nanotechnology
Biomaterials
Yanek JiménezAndrade
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
7
6
179
Pharmacology
Immunology
Katlynn Bugda Gwilt
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
7
6
160
Pharmacology
Trace Amines
Chemosensing
Epithelial Biology
Shuchi Mittal
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
7
6
906
Drug Discovery and development
David Merola
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
6
4
134
pharmacoepidemiology
comparative effectiveness research
real-world evidence
oncology
clinical pharmacy
Dina Elharouni
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
6
3
80
Pharmacogenomics
Precision Oncology
Clinical Bioinformatics
Decision Intelligence
Sungho Bea
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
5
3
151
Sulyman Barkho
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
5
4
131
drug discovery
biochemistry
biophysics
chemical biology
Graziela Scheuer Gomes
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
3
2
76
Pharmacy
nanotechnology
nanocapsules
autoimmune diseases
immunology
Ben Berger
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
3
2
51
pharmaceutical innovation
health economics
Nastaran Pourshadi
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
3
2
37
Alexandra Whiddon Tatara
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
3
1
44
Internal medicine
infectious diseases
venous thromboembolism
anticoagulation
diabetes mellitus
Azadeh Mahdavinia
Harvard University
Cambridge, United States
Metrics
H-Index
i10 Index
Citation Counts
2
1
32